Association between prostinogen (KLK15) genetic variants and prostate cancer risk and aggressiveness in australia and a meta-analysis of GWAS data

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Batra, Jyotsna ^a,b   Lose, Felicity ^b   O'Mara, Tracy ^a,b   Marquart, Louise ^b   Stephens, Carson ^a   Alexander, Kimberly ^a   Srinivasan, Srilakshmi ^a   Eeles, Rosalind A ^c   Easton, Douglas F ^d   Al Olama, Ali Amin ^d   Kote Jarai, Zsofia ^c   Guy, Michelle ^c   Muir, Kenneth ^e   Lophatananon, Artitaya ^e   Rahman, Aneela A ^f   Neal, David E ^g   Hamdy, Freddie C ^h   Donovan, Jenny L ⁱ   Chambers, Suzanne ^j,k   Gardiner, Robert A ^l   Aitken, Joanne ^k   Yaxley, John ^m   Kedda, Mary Anne ^a   Clements, Judith A ^a   Spurdle, Amanda B ^b   more..

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^d IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^e UNIVERSITY OF WARWICK   (United Kingdom)

^f UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^h JOHN RADCLIFFE HOSPITAL   (United Kingdom)

ⁱ UNIVERSITY OF BRISTOL   (United Kingdom)

^j GRIFFITH UNIVERSITY   (Australia)

^k VIERTEL CENTRE FOR RESEARCH IN CANCER CONTROL   (Australia)

^l UNIVERSITY OF QUEENSLAND   (Australia)

^m Mater Private Hospital Brisbane   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

KALLIKREIN; KALLIKREIN 15; UNCLASSIFIED DRUG; KLK15 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; AUSTRALIA; BIOINFORMATICS; CANCER CELL; CANCER GENETICS; CANCER GROWTH; CANCER RISK; CELL DIFFERENTIATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; GENE LINKAGE DISEQUILIBRIUM; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GLEASON SCORE; HUMAN; HUMAN CELL; KLK15 GENE; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PREDICTION; PROSTATE CANCER; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM; BIOLOGY; CHROMOSOME MAP; DEMOGRAPHY; DNA SEQUENCE; GENETIC DATABASE; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROMOTER REGION; PROSTATE TUMOR; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; CHROMOSOME MAPPING; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; DEMOGRAPHY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; KALLIKREINS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; QUEENSLAND; RISK FACTORS; SEQUENCE ANALYSIS, DNA;

EID: 81755162937     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026527     Document Type: Article

References (30)

1. Crawford ED, (2003) Epidemiology of prostate cancer. Urology 62: 3-12.
2. Steven SC, Ingrid JH, (2002) A Review of Genetic Polymorphisms and Prostate Cancer Risk. Annals of epidemiology 12: 182-196.
3. Witte JS, (2009) Prostate cancer genomics: towards a new understanding. Nat Rev Genet 10: 77-82.
4. Borgono CA, Diamandis EP, (2004) The emerging roles of human tissue kallikreins in cancer. Nat Rev Cancer 4: 876-890.
5. Emami N, Diamandis EP, (2008) Utility of kallikrein-related peptidases (KLKs) as cancer biomarkers. Clin Chem 54: 1600-1607.
6. Klein RJ, Hallden C, Cronin AM, Ploner A, Wiklund F, et al. (2010) Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancer. Cancer Prev Res (Phila) 3: 611-619.
7. Lawrence MG, Lai J, Clements JA, (2010) Kallikreins on steroids: structure, function, and hormonal regulation of prostate-specific antigen and the extended kallikrein locus. Endocr Rev 31: 407-446.
8. Clements J, Hooper J, Dong Y, Harvey T, (2001) The expanded human kallikrein (KLK) gene family: genomic organisation, tissue-specific expression and potential functions. Biol Chem 382: 5-14.
9. Kurlender L, Borgono C, Michael IP, Obiezu C, Elliott MB, et al. (2005) A survey of alternative transcripts of human tissue kallikrein genes. Biochim Biophys Acta 1755: 1-14.
10. Parikh H, Deng Z, Yeager M, Boland J, Matthews C, et al. (2010) A comprehensive resequence analysis of the KLK15-KLK3-KLK2 locus on chromosome 19q13.33. Hum Genet 127: 91-99.
11. Yousef GM, Scorilas A, Jung K, Ashworth LK, Diamandis EP, (2001) Molecular cloning of the human kallikrein 15 gene (KLK15). Up-regulation in prostate cancer. J Biol Chem 276: 53-61.
12. Mavridis K, Avgeris M, Koutalellis G, Stravodimos K, Scorilas A, (2010) Expression analysis and study of the KLK15 mRNA splice variants in prostate cancer and benign prostatic hyperplasia. Cancer Science 101: 693-699.
13. Stephan C, Yousef GM, Scorilas A, Jung K, Jung M, et al. (2003) Quantitative analysis of kallikrein 15 gene expression in prostate tissue. J Urol 169: 361-364.
14. Rabien A, Fritzsche FR, Jung M, Tolle A, Diamandis EP, et al. (2010) KLK15 is a prognostic marker for progression-free survival in patients with radical prostatectomy. Int J Cancer 127: 2386-2394.
15. Yousef GM, Scorilas A, Katsaros D, Fracchioli S, Iskander L, et al. (2003) Prognostic Value of the Human Kallikrein Gene 15 Expression in Ovarian Cancer. J Clin Oncol 21: 3119-3126.
16. Yousef GM, Scorilas A, Magklara A, Memari N, Ponzone R, et al. (2002) The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer. Br J Cancer 87: 1294-1300.
17. Lai J, Kedda MA, Hinze K, Smith RL, Yaxley J, et al. (2007) PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibility. Carcinogenesis 28: 1032-1039.
18. Batra J, Tan OL, O'Mara T, Zammit R, Nagle CM, et al. (2010) Kallikrein-related peptidase 10 (KLK10) expression and single nucleotide polymorphisms in ovarian cancer survival. Int J Gynecol Cancer 20: 529-536.
19. Ahn J, Berndt SI, Wacholder S, Kraft P, Kibel AS, et al. (2008) Variation in KLK genes, prostate-specific antigen and risk of prostate cancer. Nat Genet 40: 1032-1034.
20. Pal P, Xi H, Sun G, Kaushal R, Meeks JJ, et al. (2007) Tagging SNPs in the kallikrein genes 3 and 2 on 19q13 and their associations with prostate cancer in men of European origin. Hum Genet 122: 251-259.
21. Nam RK, Zhang WW, Trachtenberg J, Diamandis E, Toi A, et al. (2003) Single nucleotide polymorphism of the human kallikrein-2 gene highly correlates with serum human kallikrein-2 levels and in combination enhances prostate cancer detection. J Clin Oncol 21: 2312-2319.
22. Morote J, Del Amo J, Borque A, Ars E, Hernandez C, et al. (2010) Improved prediction of biochemical recurrence after radical prostatectomy by genetic polymorphisms. J Urol 184: 506-511.
23. Kote-Jarai Z, Easton DF, Stanford JL, Ostrander EA, Schleutker J, et al. (2008) Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium. Cancer Epidemiol Biomarkers Prev 17: 2052-2061.
24. Eeles RA, Kote-Jarai Z, Giles GG, Olama AA, Guy M, et al. (2008) Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 40: 316-321.
25. Yeager M, Orr N, Hayes RB, Jacobs KB, Kraft P, et al. (2007) Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 39: 645-649.
26. Batra J, Nagle CM, O'Mara T, Higgins M, Dong Y, et al. (2011) A Kallikrein 15 (KLK15) single nucleotide polymorphism located close to a novel exon shows evidence of association with poor ovarian cancer survival. BMC Cancer In Press.
27. Parikh H, Wang Z, Pettigrew KA, Jia J, Daugherty S, et al. (2011) Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels. Hum Genet.
28. Eeles RA, Kote-Jarai Z, Al Olama AA, Giles GG, Guy M, et al. (2009) Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet 41: 1116-1121.
29. Moretti RM, Marelli MM, Motta M, Limonta P, (2002) Role of the orphan nuclear receptor ROR alpha in the control of the metastatic behavior of androgen-independent prostate cancer cells. Oncol Rep 9: 1139-1143.
30. Baade PD, Aitken JF, Ferguson M, Gardiner RA, Chambers SK, (2010) Diagnostic and treatment pathways for men with prostate cancer in Queensland: investigating spatial and demographic inequalities. BMC Cancer 10: 452.